 Preston Bratcher
Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystic Fibrosis Transmembrane Conductance Regulator | 12 | 2022 | 287 | 5.490 |
Why?
| | Cystic Fibrosis | 15 | 2022 | 955 | 3.470 |
Why?
| | Aminophenols | 8 | 2022 | 112 | 2.290 |
Why?
| | Benzodioxoles | 7 | 2022 | 83 | 1.990 |
Why?
| | Quinolones | 6 | 2022 | 97 | 1.550 |
Why?
| | Indoles | 3 | 2022 | 304 | 1.440 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 3 | 2014 | 29 | 1.330 |
Why?
| | Streptococcus pneumoniae | 4 | 2010 | 133 | 1.250 |
Why?
| | Chloride Channel Agonists | 3 | 2021 | 62 | 1.010 |
Why?
| | Pyrrolidines | 2 | 2022 | 55 | 0.950 |
Why?
| | Epithelial Cells | 5 | 2021 | 950 | 0.870 |
Why?
| | Neutrophils | 6 | 2019 | 1176 | 0.790 |
Why?
| | Pyrazoles | 2 | 2022 | 362 | 0.780 |
Why?
| | Bacterial Capsules | 3 | 2010 | 28 | 0.770 |
Why?
| | Pyridines | 2 | 2022 | 425 | 0.760 |
Why?
| | Epithelial Sodium Channels | 1 | 2021 | 12 | 0.740 |
Why?
| | Quinolines | 1 | 2021 | 129 | 0.720 |
Why?
| | Chlorides | 1 | 2020 | 127 | 0.680 |
Why?
| | Tetraspanin 30 | 2 | 2018 | 9 | 0.660 |
Why?
| | Receptors, Interleukin-8B | 1 | 2018 | 23 | 0.640 |
Why?
| | Pseudomonas | 1 | 2018 | 26 | 0.640 |
Why?
| | Klebsiella pneumoniae | 1 | 2018 | 41 | 0.630 |
Why?
| | Matrix Metalloproteinase 9 | 3 | 2022 | 119 | 0.580 |
Why?
| | Leukocytes | 1 | 2018 | 276 | 0.570 |
Why?
| | Epithelium | 3 | 2021 | 295 | 0.520 |
Why?
| | Drug Combinations | 3 | 2022 | 287 | 0.510 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 497 | 0.500 |
Why?
| | CD11b Antigen | 1 | 2015 | 57 | 0.490 |
Why?
| | Polypropylenes | 1 | 2013 | 14 | 0.450 |
Why?
| | Serum Albumin, Bovine | 1 | 2013 | 61 | 0.430 |
Why?
| | Coated Materials, Biocompatible | 1 | 2013 | 54 | 0.430 |
Why?
| | Antibodies, Bacterial | 2 | 2010 | 119 | 0.410 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 797 | 0.410 |
Why?
| | Pneumococcal Infections | 2 | 2010 | 91 | 0.400 |
Why?
| | Monocytes | 1 | 2015 | 502 | 0.400 |
Why?
| | Aminopyridines | 3 | 2021 | 81 | 0.380 |
Why?
| | Biosynthetic Pathways | 1 | 2010 | 19 | 0.360 |
Why?
| | Mutation | 6 | 2022 | 3344 | 0.360 |
Why?
| | Serotyping | 4 | 2010 | 28 | 0.350 |
Why?
| | Bacteriological Techniques | 1 | 2010 | 65 | 0.350 |
Why?
| | Cells, Cultured | 6 | 2021 | 3881 | 0.320 |
Why?
| | Humans | 28 | 2022 | 114623 | 0.300 |
Why?
| | Immunity, Innate | 1 | 2012 | 720 | 0.280 |
Why?
| | Exosomes | 2 | 2019 | 91 | 0.270 |
Why?
| | Bronchi | 2 | 2019 | 231 | 0.260 |
Why?
| | NIH 3T3 Cells | 2 | 2021 | 137 | 0.230 |
Why?
| | Genotype | 3 | 2021 | 1760 | 0.230 |
Why?
| | Animals | 15 | 2024 | 31694 | 0.210 |
Why?
| | Proline | 2 | 2019 | 72 | 0.200 |
Why?
| | Mustard Gas | 1 | 2024 | 117 | 0.200 |
Why?
| | Chemical Warfare Agents | 1 | 2024 | 119 | 0.200 |
Why?
| | Dimethyl Sulfoxide | 1 | 2022 | 43 | 0.200 |
Why?
| | 1-Methyl-3-isobutylxanthine | 1 | 2021 | 24 | 0.200 |
Why?
| | Colforsin | 1 | 2021 | 48 | 0.200 |
Why?
| | Vaping | 1 | 2022 | 45 | 0.190 |
Why?
| | Respiratory System | 2 | 2022 | 137 | 0.190 |
Why?
| | Electrophysiology | 1 | 2021 | 201 | 0.190 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 71 | 0.190 |
Why?
| | Heterozygote | 1 | 2021 | 251 | 0.180 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2785 | 0.180 |
Why?
| | Ion Transport | 1 | 2020 | 55 | 0.180 |
Why?
| | Drug Monitoring | 2 | 2018 | 184 | 0.170 |
Why?
| | Forced Expiratory Volume | 2 | 2018 | 475 | 0.170 |
Why?
| | Isocyanates | 1 | 2020 | 14 | 0.170 |
Why?
| | Nasal Mucosa | 1 | 2020 | 93 | 0.170 |
Why?
| | Lipopolysaccharides | 3 | 2016 | 821 | 0.170 |
Why?
| | Respiratory Function Tests | 2 | 2018 | 522 | 0.170 |
Why?
| | Prodrugs | 1 | 2019 | 42 | 0.160 |
Why?
| | Adult | 7 | 2020 | 30528 | 0.160 |
Why?
| | Biological Products | 1 | 2021 | 166 | 0.160 |
Why?
| | Sweat | 1 | 2018 | 38 | 0.160 |
Why?
| | Mice | 6 | 2022 | 14860 | 0.150 |
Why?
| | Down-Regulation | 1 | 2021 | 594 | 0.150 |
Why?
| | Trachea | 1 | 2020 | 224 | 0.150 |
Why?
| | Homozygote | 1 | 2018 | 187 | 0.150 |
Why?
| | Temperature | 1 | 2021 | 565 | 0.150 |
Why?
| | Male | 11 | 2022 | 55554 | 0.150 |
Why?
| | Respiratory Mucosa | 1 | 2020 | 251 | 0.150 |
Why?
| | Tissue Plasminogen Activator | 1 | 2020 | 225 | 0.150 |
Why?
| | Airway Obstruction | 1 | 2020 | 168 | 0.150 |
Why?
| | Cilia | 1 | 2019 | 162 | 0.150 |
Why?
| | Lung | 5 | 2024 | 3558 | 0.150 |
Why?
| | Inflammation | 4 | 2022 | 2477 | 0.150 |
Why?
| | Pseudomonas aeruginosa | 2 | 2016 | 298 | 0.140 |
Why?
| | Sequence Analysis, DNA | 2 | 2010 | 723 | 0.140 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2017 | 25 | 0.140 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 191 | 0.140 |
Why?
| | ELAV-Like Protein 1 | 1 | 2017 | 15 | 0.140 |
Why?
| | Escherichia coli | 2 | 2012 | 720 | 0.140 |
Why?
| | Gene Deletion | 1 | 2018 | 356 | 0.140 |
Why?
| | Aztreonam | 1 | 2016 | 8 | 0.140 |
Why?
| | Transcriptome | 1 | 2022 | 725 | 0.140 |
Why?
| | Anti-Infective Agents | 1 | 2019 | 225 | 0.140 |
Why?
| | Doxycycline | 1 | 2017 | 55 | 0.140 |
Why?
| | Leukocyte Elastase | 2 | 2019 | 79 | 0.140 |
Why?
| | Tobramycin | 1 | 2016 | 47 | 0.140 |
Why?
| | Pulmonary Emphysema | 1 | 2019 | 267 | 0.140 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2017 | 60 | 0.130 |
Why?
| | Azithromycin | 1 | 2016 | 80 | 0.130 |
Why?
| | Serine Endopeptidases | 1 | 2016 | 102 | 0.130 |
Why?
| | Microglia | 1 | 2017 | 202 | 0.120 |
Why?
| | Pseudomonas Infections | 1 | 2016 | 184 | 0.120 |
Why?
| | Cell Line | 3 | 2017 | 2635 | 0.110 |
Why?
| | Mitochondrial Proteins | 1 | 2016 | 219 | 0.110 |
Why?
| | Medication Adherence | 1 | 2018 | 536 | 0.110 |
Why?
| | Statistics as Topic | 1 | 2015 | 292 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2014 | 197 | 0.110 |
Why?
| | Logistic Models | 1 | 2018 | 1840 | 0.110 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1518 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2016 | 287 | 0.110 |
Why?
| | Adsorption | 1 | 2013 | 119 | 0.110 |
Why?
| | Reference Values | 1 | 2014 | 742 | 0.110 |
Why?
| | Smoking | 1 | 2020 | 1380 | 0.110 |
Why?
| | Female | 8 | 2020 | 59466 | 0.100 |
Why?
| | Genes, Bacterial | 2 | 2009 | 157 | 0.100 |
Why?
| | DNA, Bacterial | 2 | 2010 | 311 | 0.100 |
Why?
| | Proteolysis | 1 | 2012 | 142 | 0.100 |
Why?
| | Dinoprostone | 2 | 2022 | 184 | 0.100 |
Why?
| | Multilocus Sequence Typing | 1 | 2010 | 12 | 0.090 |
Why?
| | Gene Order | 1 | 2010 | 24 | 0.090 |
Why?
| | Cattle | 1 | 2013 | 920 | 0.090 |
Why?
| | Gene Transfer, Horizontal | 1 | 2010 | 27 | 0.090 |
Why?
| | Bacterial Typing Techniques | 1 | 2010 | 40 | 0.090 |
Why?
| | Phagocytosis | 1 | 2012 | 350 | 0.090 |
Why?
| | Cross Reactions | 1 | 2010 | 117 | 0.090 |
Why?
| | Matrix Metalloproteinases | 1 | 2011 | 89 | 0.090 |
Why?
| | Korea | 1 | 2009 | 8 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2010 | 323 | 0.090 |
Why?
| | Recombination, Genetic | 1 | 2010 | 176 | 0.080 |
Why?
| | Macrophages, Alveolar | 1 | 2012 | 347 | 0.080 |
Why?
| | Genetic Loci | 1 | 2010 | 262 | 0.080 |
Why?
| | Cluster Analysis | 1 | 2010 | 455 | 0.080 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2009 | 58 | 0.080 |
Why?
| | Oligopeptides | 2 | 2019 | 236 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2018 | 9084 | 0.070 |
Why?
| | Escherichia coli Proteins | 1 | 2009 | 162 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2014 | 2762 | 0.070 |
Why?
| | Phylogeny | 1 | 2010 | 789 | 0.070 |
Why?
| | Protein Binding | 1 | 2012 | 1889 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2114 | 0.070 |
Why?
| | Evolution, Molecular | 1 | 2010 | 430 | 0.070 |
Why?
| | Calcium | 1 | 2012 | 1104 | 0.070 |
Why?
| | Sputum | 2 | 2019 | 285 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2009 | 1083 | 0.070 |
Why?
| | Sensitivity and Specificity | 1 | 2010 | 1691 | 0.060 |
Why?
| | Mesna | 1 | 2024 | 17 | 0.060 |
Why?
| | Rats | 2 | 2024 | 4958 | 0.060 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1262 | 0.050 |
Why?
| | Sodium | 1 | 2024 | 183 | 0.050 |
Why?
| | Angiotensins | 1 | 2022 | 10 | 0.050 |
Why?
| | Mesocricetus | 1 | 2022 | 29 | 0.050 |
Why?
| | Renin | 1 | 2022 | 31 | 0.050 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2022 | 57 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2009 | 1314 | 0.050 |
Why?
| | Thromboplastin | 1 | 2022 | 71 | 0.050 |
Why?
| | Cricetinae | 1 | 2022 | 253 | 0.050 |
Why?
| | Lubiprostone | 1 | 2022 | 9 | 0.050 |
Why?
| | Receptors, Prostaglandin E, EP2 Subtype | 1 | 2022 | 6 | 0.050 |
Why?
| | Antidotes | 1 | 2024 | 135 | 0.050 |
Why?
| | Cotinine | 1 | 2022 | 69 | 0.050 |
Why?
| | Prostaglandins | 1 | 2022 | 77 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2022 | 122 | 0.050 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2019 | 913 | 0.050 |
Why?
| | Superoxide Dismutase | 1 | 2022 | 305 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 453 | 0.040 |
Why?
| | Cyanates | 1 | 2019 | 4 | 0.040 |
Why?
| | Nicotine | 1 | 2022 | 265 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 98 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 448 | 0.040 |
Why?
| | Thiocyanates | 1 | 2019 | 29 | 0.040 |
Why?
| | Selenium Compounds | 1 | 2019 | 21 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 498 | 0.040 |
Why?
| | Smokers | 1 | 2020 | 128 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3531 | 0.040 |
Why?
| | Oscillometry | 1 | 2019 | 33 | 0.040 |
Why?
| | Anti-Bacterial Agents | 2 | 2019 | 1477 | 0.040 |
Why?
| | Chemotaxis | 1 | 2019 | 130 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 4689 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 228 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 188 | 0.040 |
Why?
| | Smoke | 1 | 2019 | 123 | 0.040 |
Why?
| | Video Recording | 1 | 2019 | 143 | 0.040 |
Why?
| | Integrins | 1 | 2019 | 79 | 0.040 |
Why?
| | Microscopy | 1 | 2019 | 125 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 385 | 0.040 |
Why?
| | alpha 1-Antitrypsin | 1 | 2019 | 100 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1139 | 0.040 |
Why?
| | Alabama | 1 | 2017 | 28 | 0.040 |
Why?
| | Young Adult | 3 | 2017 | 10455 | 0.040 |
Why?
| | Matrix Metalloproteinase 12 | 1 | 2017 | 7 | 0.040 |
Why?
| | Drug Administration Routes | 1 | 2016 | 40 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1143 | 0.030 |
Why?
| | Signal Transduction | 2 | 2022 | 4509 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 590 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 9108 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 299 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 267 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2016 | 239 | 0.030 |
Why?
| | Drug Interactions | 1 | 2016 | 338 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2019 | 436 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2020 | 2218 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 811 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 768 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1369 | 0.030 |
Why?
| | Spinal Cord | 1 | 2017 | 347 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 433 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 866 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2017 | 1660 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2380 | 0.030 |
Why?
| | Algorithms | 1 | 2019 | 1466 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1842 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 2796 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 16 | 0.020 |
Why?
| | Pancreatic Elastase | 1 | 2011 | 66 | 0.020 |
Why?
| | Airway Remodeling | 1 | 2011 | 57 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 2011 | 104 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 2565 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2017 | 2552 | 0.020 |
Why?
| | Chromosomes, Bacterial | 1 | 2009 | 7 | 0.020 |
Why?
| | Origin Recognition Complex | 1 | 2009 | 3 | 0.020 |
Why?
| | DNA Fragmentation | 1 | 2009 | 47 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2009 | 61 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3003 | 0.020 |
Why?
| | DNA Replication | 1 | 2009 | 202 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2009 | 285 | 0.020 |
Why?
| | Brain | 1 | 2017 | 2371 | 0.020 |
Why?
| | Chronic Disease | 1 | 2011 | 1578 | 0.020 |
Why?
| | Phosphorylation | 1 | 2009 | 1569 | 0.020 |
Why?
| | Macrophages | 1 | 2011 | 1261 | 0.010 |
Why?
| | Models, Biological | 1 | 2011 | 1620 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 17831 | 0.010 |
Why?
| | Aged | 1 | 2017 | 19061 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 26719 | 0.010 |
Why?
|
|
Bratcher's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|